Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

NETWORK 1

Study Type

Interventional 158Observational 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 17Lung Neoplasms 6Ovarian Neoplasms 5Small Cell Lung Carcinoma 4Neoplasms 3Uterine Cervical Neoplasms 2Triple Negative Breast Neoplasms 2Breast Neoplasms 2Adenocarcinoma, Bronchiolo-Alveolar 2Adenocarcinoma of Lung 2Unspecified Childhood Solid Tumor, Protocol Specific 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sexual Dysfunction, Physiological 1Sarcopenia 1Recurrence 1Pancreatic Neoplasms 1PROMs 1Ototoxicity 1Neurotoxicity Syndromes 1Neoplastic Cells, Circulating 1Neoplasm Metastasis 1Hearing Loss 1Fatigue 1Fallopian Tube Neoplasms 1Eunuchism 1Esophageal Neoplasms 1Erectile Dysfunction 1Chemotherapy-induced Peripheral Neuropathy 1Central Nervous System Neoplasms 1

Interventions

Surveys and Questionnaires 5niraparib 2Polymerase Chain Reaction 2Immunohistochemistry 2Geriatric Assessment 2Gene Expression Profiling 2Flow Cytometry 2Blood Specimen Collection 2rucaparib 1Tissue Banks 1Taxes 1Sutures 1Surgical Procedures, Operative 1Standard of Care 1Specimen Handling 1Ropivacaine 1Quality of Life 1Psychiatric Rehabilitation 1Patient Reported Outcome Measures 1Paracentesis 1Papanicolaou Test 1Paclitaxel 1Observation 1Neuroimaging 1Neoadjuvant Therapy 1Molecular Diagnostic Techniques 1Mitomycin 1Microarray Analysis 1Mental Status and Dementia Tests 1Magnetic Resonance Spectroscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Fallopian Tube Neoplasms × Carboplatin × Clear all
NCT01366183 2021-09-30

Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer

GOG Foundation

Unknown
290 enrolled
Gynecologic

Fallopian Tube Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡